Originally published In Press as doi:10.1074/jbc.M002049200 on June 6, 2000
J. Biol. Chem., Vol. 275, Issue 35, 27177-27185, September 1, 2000
The Conformation of Calreticulin Is Influenced by the Endoplasmic
Reticulum Luminal Environment*
Elaine F.
Corbett
§,
Karolina M.
Michalak
,
Kim
Oikawa¶,
Steve
Johnson
,
Iain D.
Campbell
,
Paul
Eggleton
,
Cyril
Kay¶, and
Marek
Michalak
**
From the
Canadian Institutes of Health Research Group
in Molecular Biology of Membranes, the ¶ Canadian Institutes of
Health Research Group in Protein Structure and Function, Protein
Engineering Network of Centers of Excellence and the Department of
Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
and
Medical Research Council Immunochemistry Unit, Department of
Biochemistry, University of Oxford, OX1 3QU
Oxford, United Kingdom
Received for publication, March 13, 2000, and in revised form, May 12, 2000
 |
ABSTRACT |
In order to understand the dynamics
of the endoplasmic reticulum (ER) luminal environment, we investigated
the role of Ca2+, Zn2+, and ATP on
conformational changes of calreticulin. Purified calreticulin was
digested with trypsin in the presence or absence of Ca2+,
Zn2+, and ATP. At low Ca2+ concentration (<100
µM), calreticulin is rapidly and fully degraded by
trypsin, indicating that under these conditions the protein is in a
highly trypsin-susceptible conformation. Increasing Ca2+
concentration up to 500 µM or 1 mM resulted
in protection of the full-length calreticulin and in generation of the
27-kDa fragment highly resistant to trypsin digestion. The 27-kDa
protease-resistant core of the protein represented the
NH2-terminal half of calreticulin and was identified by its
reactivity with specific antibodies and by NH2-terminal
amino acid sequence analysis. Ca2+-dependent
changes in calreticulin's sensitivity to proteolysis indicate that
agonist-induced fluctuation in the free ER luminal Ca2+
concentration may affect the protein conformation and function. Trypsin
digestion of calreticulin in the presence of Zn2+ resulted
in the formation of a 17-kDa central protease-resistant core in the
protein corresponding to the central region of the protein, indicating
that under these conditions the N- and C-domains of the protein are in
an extended conformation. Here we also show that calreticulin is an
ATP-binding protein but that it does not contain detectable ATPase
activity. Digestion of the protein with trypsin in the presence of
Mg2+-ATP protects the full-length protein. These results
indicate that calreticulin may undergo frequent, ion-induced
conformation changes, which may affect its function and its ability to
interact with other proteins in the lumen of the ER.
 |
INTRODUCTION |
The endoplasmic reticulum
(ER)1 plays an essential role
in a variety of cellular processes, including the synthesis,
post-translational modification, and folding of membrane-associated and
secreted proteins (1-6). The lumen of the ER is a dynamic
environment perfectly designed for the task of protein folding. It
contains a high concentration of Ca2+ binding chaperones
and an optimal concentration of ions and nucleotides for protein
folding, modification, and assembly.
Several studies have indicated that changes in the concentration of
Ca2+ in the ER lumen ([Ca2+]ER)
affect many ER functions, including the synthesis, folding, post-translational modification, and secretion of proteins; protein conformation; and chaperone-chaperone or chaperone-substrate
interactions (7-15). The ER lumen also contains ATP, which is required
to support the correct folding and formation of disulfide bonds in many
proteins (16-18). An ATP transporter has been identified in the ER
(19, 20), and the ER proteins PDI and BiP are known to bind/utilize ATP
in their chaperone action (21-25).
Calreticulin is one of the major Ca2+-binding proteins in
the lumen of the ER. The protein can be divided into three main
structural regions (26). The highly conserved N-domain binds
Zn2+ with high capacity (27), whereas the proline-rich
P-domain binds Ca2+ with high affinity (28). The C-domain,
which may play a role in the Ca2+ storage function of
calreticulin, binds Ca2+ with high capacity (28). In the
lumen of the ER, the protein functions as a chaperone and a modulator
of Ca2+ homeostasis (26). Calreticulin binds
monoglucosylated oligosaccharides (4) and misfolded proteins (29, 30).
Importantly, calreticulin responds to fluctuating Ca2+
levels in the lumen of the ER by modulating its ability to interact with other ER proteins and substrates (15). We have suggested that the
binding of Ca2+ to the C-domain of calreticulin may allow
it to function as a "Ca2+ sensor" for other ER
chaperones (15). However, the precise effects of ER constituents such
as Ca2+, Zn2+, nucleotides, and other proteins
on the structure and function of calreticulin remain to be determined.
In this study, we have investigated the effect of changes in the ER
luminal environment (specifically Ca2+, Zn2+,
and ATP) on conformational changes in calreticulin. We show that
Ca2+, Zn2+, and ATP affect the tertiary
structure of calreticulin, as indicated by changes in its sensitivity
to protease digestion. Furthermore, we show directly that calreticulin
is an ATP-binding protein but does not contain detectable ATPase
activity. Our results indicate that dynamic changes within the lumen of
the ER can have profound effects on calreticulin's structure,
stability, and function.
 |
EXPERIMENTAL PROCEDURES |
Materials--
ATP-agarose, CL-2B-agarose, bovine IgG,
Mg2+-ATP, ADP, AMP, GTP, GDP, trypsin, V8 protease,
cathepsin G, and elastase were from Sigma. The Pichia
expression system was from Invitrogen. SDS-PAGE reagents and molecular
weight markers were from Bio-Rad. Peroxidase-conjugated rabbit
anti-goat and goat anti-rabbit IgGs were from Jackson ImmunoResearch Laboratories. The ECL detection kit for Western blotting was from Amersham Pharmacia Biotech. All chemicals were of the highest grade available.
Expression and Purification of Recombinant Calreticulin in Pichia
Protein Expression System--
The cDNA of full-length rabbit
calreticulin was cloned into pPIC-9 and transformed into the
Pichia KM71 strain as recommended by the manufacturer. The
expression of calreticulin was induced with 0.5% methanol. The protein
was purified by DEAE-Sepharose and Resource Q FPLC column
chromatography.2 The
NH2-terminal amino acid sequence of full-length
calreticulin expressed in Pichia was
NH2-EAYVEF1EPVVYFL-, where the
underlined residues correspond to the amino acid sequence of mature
calreticulin. Biochemical and biophysical analysis of the recombinant
calreticulin using mass spectroscopy, CD analysis, disulfide mapping,
Ca2+ binding measurements, and antibody reactivity revealed
that it was identical to the native, tissue-purified
protein.2
Proteolytic Digestions--
Purified, recombinant calreticulin
expressed in Pichia was incubated with trypsin at 1:100
(trypsin/protein; w/w) at 37 °C and in the presence or absence of
varying concentrations of Ca2+, Zn2+, and
Mg-ATP (as indicated in the figure legends). Aliquots were taken at the
indicated time points, and the reaction was stopped by the addition of
the Laemmli sample buffer (31). Calreticulin (15 µg) was also
digested in the absence (5 mM EDTA) or in the presence of
Ca2+ (2 mM Ca2+) with elastase, V8
protease, and cathepsin G at a calreticulin/enzyme ratio of 20:1 or
320:1 (w/w) for 2 h at 37 °C at pH 6.4 (elastase) or pH 7.4 (all others). The proteins were separated by 10 or 15% SDS-PAGE (31)
and either stained with Coomassie Blue or transferred onto a
nitrocellulose membrane (32) and probed with the indicated anti-calreticulin antibodies.
Antibodies--
Goat anti-calreticulin antibodies were
extensively characterized (33). This antibody recognizes the
C-domain but not the N-domain of calreticulin. Antibodies against the
N-terminal synthetic peptide of calreticulin were a generous gift of
Dr. K.-H. Krause (University of Geneva). This antibody
recognizes the first 12 amino acids of mature calreticulin and has also
been extensively characterized (34-36). Antibody binding was detected
with appropriate peroxidase-conjugated secondary antibodies diluted
1:10,000, followed by an ECL reaction and exposure to x-ray film.
Images of the Coomassie Blue-stained gels and x-ray films were scanned
and processed for publication using Adobe Photoshop version 5.5 software.
ATP-Agarose Chromatography--
ATP affinity chromatography was
carried out using ATP-agarose and CL-2B-agarose as the control.
Calreticulin (5 µg) was incubated at 37 °C for 60 min. with
ATP-agarose or CL-2B agarose beads (0.7 g/ml) in a binding buffer
containing 10 mM Mops, pH 7.0, 100 mM KCl, 2 mM MgCl2, 0.5 mM EGTA, and 2 mg of
bovine IgG (to block nonspecific binding). Beads were then placed in a
glass column followed by extensive washing with a binding buffer to
remove unbound proteins. ATP bound proteins were eluted with a binding buffer containing 5 mM Mg2+-ATP. Proteins
associated nonspecifically with the ATP-agarose were subsequently
eluted with 2 M NaCl. Eluted proteins were precipitated with acetone at
20 °C for 16 h, separated on 15% SDS-PAGE,
and transferred onto a nitrocellulose membrane. The membranes were probed with anti-calreticulin antibodies as described above.
Circular Dichroism and Equilibrium Sedimentation
Measurements--
CD analysis was performed at 25 °C using a Jasco
J-720 spectropolarimeter (Jasco Inc., Easton, MD), interfaced to an
Epson Equity 386/25 computer and controlled by Jasco software as
described previously (15). The instrument was calibrated with ammonium d-(+)-10 camphor sulfonate at 290.5 and 192 nm. Each sample
was scanned 10 times, and noise reduction was applied to remove the high frequency before calculating molar ellipticities. The cell path
length used was 0.02 cm, and the protein concentration was 0.6 mg/ml in
the far ultraviolet. Molar ellipticities were calculated from the
equation,
|
(Eq. 1)
|
where
obs is in millidegrees,
l represents the path length in cm, and c
represents the concentration in mol/liter × number of amino acids
in the sequence. The unit for molar ellipticity is degree
cm2/dmol. The CD spectra were analyzed for secondary
structure elements by the Contin ridge regression analysis program of
Provencher and Glöckner (37).
Sedimentation Velocity Measurements--
Sedimentation velocity
experiments were carried out at 20 °C and 50,000 rpm using the XLI
Analytical Ultracentrifuge and Interference optic following the
procedures outlined in the instruction manual (Spinco Business Center
of Beckman Instruments, Inc. Palo Alto, CA). 400 µl of sample
solution and 400 µl of dialysate were loaded into two sector CFE
centerpiece sample cells containing sapphire windows. Runs were
performed for 4 h, during which a minimum of 30 scans were taken.
The sedimentation velocity data were analyzed using the Second Moment
Method contained in the Beckman Analysis Program (Optima XL-A/XL-I Data
Analysis Software, version 4.0; Spinco Business Center of Beckman
Instruments, Inc.) to determine the sedimentation coefficient from the
following relationship,
|
(Eq. 2)
|
where S represents the observed sedimentation
coefficient;
represents angular velocity; r represents
radial position of the solvent/protein boundary; and t
represents the time in seconds. By measuring the movement of the
boundary over time and plotting ln r versus
2t, a straight line should be obtained with
the slope = S.
The program Sednterp (Sedimentation Interpretation Program, version
1.01, created by David B. Haynes (Magdelan College), Tom Laue
(University of New Hampshire), and John Philo (Amgen)) was then used to
calculate S20,w according to the
following relationship,
|
(Eq. 3)
|
where S20,w represents the
sedimentation coefficient corrected to water at 20 °C; s
represents the observed sedimentation coefficient;
t
represents the viscosity of water at run temperature;
20
represents the viscosity of water at 20 °C;
sol
represents the viscosity of sample solution at known temperature
t';
w represents the viscosity of water at
t' degrees;
20,w represents the
density of water at 20 °C;
t, sol represents the density
of sample solution at run temperature; and
represents the partial
volume of the solute.
Miscellaneous Methods--
ATP hydrolysis was carried out using
a coupled enzyme system (38). Protein concentration was determined by
the procedure of Bradford (39). NH2-terminal sequence
analysis of native and recombinant proteins was carried out on samples,
which were electroblotted to Immobilon (polyvinylidene difluoride)
membranes (40). Free Ca2+ concentrations were calculated
using Max Chelator, Winmaxc version 1.70.
 |
RESULTS |
Ca2+-dependent Conformation Changes in
Calreticulin--
In response to agonist stimulation of cells, the
[Ca2+]ER undergoes dynamic changes (41). In a
steady-state situation, the [Ca2+]ER is in
excess of 400 µM. After agonist-evoked Ca2+
release from the ER, the [Ca2+]ER is reduced
to <50 µM (42). Therefore, upon agonist stimulation, Ca2+-binding proteins in the lumen of the ER, including
calreticulin, experience frequent changes in Ca2+
concentration. To evaluate the importance of
[Ca2+]ER in calreticulin's function, we
investigated the effect of Ca2+ on calreticulin's
sensitivity to protease digestion. Large quantities of calreticulin
were expressed in Pichia and purified.2 The
purified protein was digested with trypsin (1:100,
trypsin/calreticulin) over a range of physiologically relevant
Ca2+ concentrations, from low (0-100 µM,
representing empty Ca2+ stores) to high (500-1000
µM, representing full Ca2+ stores) (41). Fig.
1 shows that in the absence of
Ca2+ (A) or in the presence of 100 µM Ca2+ (B) calreticulin was
almost completely degraded by trypsin within 2 min of incubation. This
indicates that at low concentrations of Ca2+ calreticulin
was highly susceptible to digestion by trypsin. In contrast, at
Ca2+ concentrations of 500 µM (C)
or 1 mM (D) calreticulin exhibited resistance to
trypsin digestion, and when digestion occurred it resulted in the
generation of a 27-kDa protein, which was highly resistant to further
trypsin digestion (Fig. 1, C and D). At high Ca2+ concentration, the proteolytic activity of trypsin is
highly increased (43, 44), yet the 27-kDa fragment was extremely resistant to trypsin digestion. Indeed, in the presence of 1 mM Ca2+, the 27-kDa fragment was resistant to
trypsin digestion for a period greater than 6 h at 37 °C (not
shown). Similar results were obtained when calreticulin was digested
with elastase, V8 protease, and cathepsin G (Fig.
2).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 1.
Trypsin digestion of calreticulin.
Purified calreticulin was incubated with trypsin at 1:100
(trypsin/protein; w/w) at 37 °C and in the presence or absence of a
varying concentration of Ca2+ as indicated. Aliquots were
taken at the time points indicated, and the proteins were separated by
SDS-PAGE and stained with Coomassie Blue as described under
"Experimental Procedures." The arrow indicates the
27-kDa protease-resistant fragment of calreticulin. The positions of
Bio-Rad molecular weight marker proteins are indicated.
|
|

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 2.
Protease digestion of calreticulin.
Purified calreticulin (lane 1) was digested with V8 protease
(A), elastase (B), and cathepsin G (C)
as described under "Experimental Procedures." Digestion was carried
out in the presence of 5 mM EDTA or in the presence of 2 mM Ca2+. Lane 2, digestion in the
presence of 2 mM Ca2+ at a calreticulin/enzyme
ratio of 320:1 (w/w); lane 3, digestion in the presence of 5 mM EDTA at a calreticulin/enzyme ratio of 320:1 (w/w);
lane 4, digestion in the presence of 2 mM
Ca2+ at a calreticulin/enzyme ratio of 20:1 (w/w);
lane 5, digestion in the presence of 5 mM EDTA
at a calreticulin/enzyme ratio of 20:1 (w/w). The arrow
indicates the 27-kDa protease-resistant fragment of calreticulin. The
positions of the molecular weight marker proteins are indicated.
|
|
To identify the Ca2+-sensitive, trypsin-resistant 27-kDa
proteolytic fragment of calreticulin, we carried out immunological analysis and NH2-terminal amino acid sequence analysis.
Calreticulin was digested with trypsin in the presence of 1 mM Ca2+ followed by Western blot analysis.
First, we used a rabbit anti-synthetic peptide antibody, which
recognizes the first 12 amino acids of mature calreticulin (34, 35).
Fig. 3A shows that these
antibodies reacted with full-length calreticulin, as expected, and with
the 27-kDa tryptic fragment of the protein. This indicates that
proteolysis proceeded from the C-terminal region of the protein,
leaving the amino-terminal region intact. Next, we used a goat
anti-calreticulin antibody, which recognizes the C-domain of
calreticulin (28). As expected, this antibody recognized the
full-length protein (Fig. 3B). However, the 27-kDa fragment
was not recognized by this antibody (Fig. 3B), indicating
that it did not include the C-domain of the protein. A short, C-domain
fragment of calreticulin (~17-kDa) was detected by the goat antibody
during the first 5 min of tryptic digestion, but this fragment was
completely digested after 10 min of incubation with trypsin (Fig.
3B). The identity of the trypsin-resistant 27-kDa fragment
was further confirmed by NH2-terminal amino acid sequence
analysis. The amino acid sequence we obtained
(NH2-EAYVEF1EPVVYFKEQF-) corresponded to the
NH2-terminal amino acid sequence of full-length recombinant
calreticulin expressed in Pichia. Identical NH3-terminal amino acid sequence
(NH2-EAYVEF1EPVVYFKEQF-) was also obtained
for a 27-kDa fragment generated with elastase, V8 protease, or
cathepsin (Fig. 2), indicating that it was identical to the 27-kDa
fragment generated with trypsin.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Immunological identification of
protease-resistant fragment of calreticulin. Purified calreticulin
was digested with trypsin (1:100; trypsin/protein; w/w) in the presence
of 1 mM Ca2+ for the time indicated. Proteins
were separated by SDS-PAGE, transferred to nitrocelluose membrane, and
probed with antibodies against the N terminus of calreticulin
(A) or the C terminus of the protein (B). The
arrow indicates the 27-kDa protease-resistant fragment. The
positions of Bio-Rad molecular weight marker proteins are
indicated.
|
|
These results indicate that calreticulin's susceptibility to tryptic
digestion, particularly in the NH2-terminal region, is altered by the binding of Ca2+. This probably results from
Ca2+-dependent conformational changes in the
protein. It appears that at Ca2+ concentrations
approximating those in full ER Ca2+ stores, the N-domain
and P-domain region of calreticulin form a 27-kDa, protease-resistant
core (Fig. 3). Under these conditions, the C-domain of the protein is
in an extended conformation, hence accessible to digestion with the protease.
Zn2+-dependent Conformational Changes in
Calreticulin--
Zn2+ plays an important regulatory role
in intracellular signal transduction, and it is an important structural
and functional element of many proteins including calreticulin (45).
Zn2+ binds to the N-domain of calreticulin, affecting its
interaction with other proteins and inducing conformational changes, as
determined by CD spectra analysis (15, 46). Therefore, we examined the effect of Zn2+ on calreticulin's protease resistance.
Calreticulin was digested in the presence of 200 µM
Zn2+, a concentration that also produces the largest
conformational change in the protein (15, 46).
Fig. 4 shows that during the first 10 min
of trypsin digestion, in the presence of 200 µM
Zn2+, two major proteolytic fragments were generated. One
was a 48-kDa fragment that reacted with anti-N-terminal calreticulin
antibodies, and the other was a 19-kDa fragment that did not react
(data not shown). During prolonged digestion, the 48-kDa fragment
disappeared, and the 19-kDa fragment was digested further, with the
removal of an additional 40-50 NH2-terminal residues,
producing a 17-kDa trypsin-resistant fragment (Fig. 4, 90-180 min).
Neither the 19-kDa nor the 17-kDa fragment reacted with antibodies
against the N- and C-terminal regions of calreticulin, suggesting that
they represented an internal region of the protein. Amino acid sequence
analysis of each fragment revealed two NH2-terminal
sequences, indicating that they are actually doublets. The N-terminal
amino acid sequences of the 19-kDa fragments were
NH2-71GQPL- and
NH2-78TVKHEQNI-. The N-terminal amino acid
sequences of the 17-kDa fragments were
NH2-118DSXYXIM-
and NH2-158IVRP-. Zn2+ has been
reported to have either no effect on trypsin activity (47) or to
increase its proteolytic activity (43, 44), yet a 17-kDa fragment was
relatively resistant to trypsin digestion in the presence of 200 µM Zn2+.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Zn2+-dependent
proteolysis of calreticulin. Purified calreticulin was incubated
with trypsin (1:100; trypsin/protein; w/w) at 37 °C in the presence
of 200 µM Zn2+. Digestion was stopped at time
points indicated, and the proteins were separated by SDS-PAGE followed
by staining with Coomassie Blue as described under "Experimental
Procedures." The arrows indicate the positions of 48-, 19-, and 17-kDa protease-resistant fragments of calreticulin. The
positions of Bio-Rad molecular weight marker proteins are
indicated.
|
|
Previous studies have shown that Zn2+ binding to
calreticulin induces conformational changes in the protein (15, 46).
Here we show that these changes lead to the formation of a central, protease-resistant core, which encompasses most of the P-domain of
calreticulin. At the same time, the N terminus and C terminus of
calreticulin may be in an extended conformation, which would explain
their accessibility to digestion by the protease (Fig. 4). Trypsin
digestion of calreticulin in the presence of both 1 mM
Ca2+ and 100 µM Zn2+ resulted in
the generation of proteolytic fragments identical to those observed in
the presence of 200 µM Zn2+ alone (data not shown).
ATP-dependent Conformational Changes in
Calreticulin--
Protein folding in the lumen of the ER requires ATP
(16-18). In order to investigate possible roles for ATP in the
function of calreticulin, we carried out limited proteolytic digestion of calreticulin in the presence and absence of Mg2+-ATP.
Mg2+ and ATP have no effect on trypsin proteolytic activity
(44, 48). Fig. 5 shows that in the
presence of 1 mM Mg2+-ATP full-length
calreticulin was quite resistant to trypsin digestion and was protected
for the first 45 min of incubation. The identity of the "protected"
full-length calreticulin was confirmed by NH2-terminal amino acid sequence analysis (data not shown). Mg2+ alone
had no protective effect (data not shown). ADP, AMP, GTP, and GDP also
did not have any protective effect (data not shown), indicating that
they did not bind to calreticulin. After 5 min of incubation with
trypsin, in addition to the full-length protein, a 30-kDa major
proteolytic fragment was observed (Fig. 5B). The 30-kDa
fragment was rapidly digested to small peptides. It appears that
calreticulin binds Mg2+-ATP and that this significantly
reduces its susceptibility to proteolytic digestion, probably via a
conformational change. A striking difference in the protective effects
of Ca2+, Zn2+, and ATP against tryptic
digestion of calreticulin is that only ATP protected the C-domain of
the protein.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
ATP-dependent proteolysis of
calreticulin. Purified calreticulin was incubated with trypsin
(1:100; trypsin/protein; w/w) at 37 °C in the presence or absence of
1 mM Mg2+-ATP. Digestion was stopped at the
time points indicated, and the proteins were separated by SDS-PAGE and
stained with Coomassie Blue as described under "Experimental
Procedures." The arrow indicates the position of
full-length calreticulin (60-kDa). The positions of Bio-Rad molecular
weight marker proteins are indicated.
|
|
Next, to mimic a more physiological environment, we investigated the
combined effect of Ca2+, Zn2+, and
Mg2+-ATP on calreticulin's sensitivity to trypsin. Fig.
6 shows the effect of ATP on the
conformation of calreticulin, in the presence of 200 µM Zn2+ (A) or 1 mM
Ca2+ (B). In the presence of Zn2+
and Mg2+-ATP, the digestion of calreticulin by trypsin
produced a 55-kDa trypsin-resistant fragment (Fig. 6A).
Under these conditions, the full-length calreticulin also showed
significant resistance (more than 2 h) to proteolysis. The
NH2-terminal amino acid sequence of the 55-kDa fragment was
NH2-78TVKHEQNID-, which is identical to the
NH2-terminal amino acid sequence of the 19-kDa tryptic
fragment produced in the presence of Zn2+ alone (Fig. 4).
The difference between these two fragments was that the 19-kDa fragment
was missing the C-domain of calreticulin. This supports our previous
observation that Mg2+-ATP protects the C-domain of
calreticulin from tryptic digestion.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
Proteolysis of calreticulin. Purified
calreticulin was incubated with trypsin (1:100; trypsin/protein; w/w)
at 37 °C in the presence of 1 mM Mg2+-ATP
and 200 µM Zn2+ (A) or in the
presence of 1 mM Mg2+-ATP and 1 mM
Ca2+ (B). The proteins were separated by
SDS-PAGE and stained with Coomassie Blue. The arrows
indicate the positions of full-length calreticulin (60 kDa) and 58-, 55-, and 27-kDa protease-resistant fragments of the protein. The
positions of Bio-Rad molecular weight marker proteins are
indicated.
|
|
Fig. 6B shows that tryptic digestion of calreticulin in the
presence of Mg2+-ATP and Ca2+ resulted in the
generation of three major fragments, one 58, one 55, and one 27 kDa.
The NH2-terminal amino acid sequence of the 58-kDa fragment
was NH2-EAYVEF1EPVVYFK-, and it corresponded to
a full-length recombinant calreticulin. This indicated that under these
conditions proteolysis of calreticulin proceeded from the
C-terminal region of the protein. The NH2-terminal amino
acid sequence of the 27-kDa fragment was also
NH2-EAYVEF1EPVVYFKEQF-. This sequence, which
corresponds to the amino-terminal sequence of full-length, mature
calreticulin, is identical to the NH2-terminal amino acid
sequence of the 27-kDa trypsin-resistant fragment obtained in the
presence of 500 µM Ca2+ (Figs. 1-3). The
27-kDa tryptic fragment obtained in the presence of
Mg2+-ATP and Ca2+, as expected, interacted with
the anti-N-terminal antibody but not with the anti-C-terminal antibody
(data not shown).
Biophysical Analysis of ATP-dependent Conformational
Changes in Calreticulin--
To examine ATP-dependent
conformational changes in calreticulin, far UV CD analysis of the
protein was carried out in the absence and presence of
Mg2+-ATP, Mg2+-ATP plus Zn2+,
Mg2+-ATP plus Ca2+, and Mg2+-ATP
plus Ca2+ and Zn2+. Control experiments were
carried out in the absence and presence of 1 mM
Ca2+, 1 mM Zn2+, and 1 mM Mg2+. The CD spectra were analyzed for
secondary structural elements by the Contin ridge regression analysis
program (37), and representative data are shown Table
I. The apoprotein has ~10%
-helix
and 66%
-sheet-
-turn, similar to values published earlier (15).
The addition of Mg2+-ATP alone and of Mg2+-ATP
with Zn2+ and/or Ca2+, resulted in small (just
outwith experimental error) changes in secondary structural
elements. Since CD changes are averaged over the entire molecule, they
are often not a very sensitive measure of small conformational
changes.
View this table:
[in this window]
[in a new window]
|
Table I
Provencher-Glöckner secondary structural analysis of calreticulin
(CRT) in the absence and presence of Mg2+-ATP and metals
Measurements were carried out in the presence of a buffer containing 25 mM PIPES, pH 6.8, 100 mM NaCl, 1 mM
dithiothreitol, 1 mM EGTA. The Zn2+ and
Ca2+ concentrations given are the free amount in the solution.
|
|
The binding of ATP to calnexin causes its ER luminal region to dimerize
(49). Therefore, we used sedimentation velocity analysis to explore
possible effects of ATP on the oligomerization of calreticulin. Table
II indicates that
S20,w values of calreticulin, at a
concentration of 3.07 mg/ml, are indistinguishable under all conditions
examined. Apparently, the binding of ATP to calreticulin does not
induce it to form oligomers.
Calreticulin Binds ATP--
ATP-dependent
conformational changes in calreticulin, as measured by its altered
sensitivity to proteolysis, suggest that the protein binds ATP. In
order to demonstrate directly that calreticulin binds ATP, we carried
out ATP affinity chromatography of the purified protein (Fig.
7A). CL-2B agarose
chromatography of the protein was carried out as a control (Fig.
7B). Calreticulin was applied to the column. This was
followed by extensive washing with the binding buffer and then elution
of ATP binding proteins with 5 mM ATP. Importantly, a
significant amount of calreticulin was bound to the ATP-agarose and was
specifically eluted with 5 mM ATP (Fig. 7A,
5 mM ATP lane). In contrast, calreticulin did
not bind to the CL-2B agarose control column (Fig. 7B).
Subsequent application of 2 M NaCl eluted no further
calreticulin, indicating that all calreticulin bound to the column had
been eluted by the ATP (Fig. 7A, 2 M NaCl
lane). These experiments demonstrate that calreticulin binds
ATP.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 7.
Direct binding of ATP to calreticulin.
Calreticulin was incubated at 37 °C with ATP-agarose or control
agarose (CL-2B Agarose) beads in a binding buffer as described under
"Experimental Procedures." ATP-bound proteins were eluted with a
binding buffer containing 5 mM Mg2+-ATP
(5 mM ATP lane) followed by a wash with 2 M NaCl (2 M NaCl lane). Eluted
proteins were separated on SDS-PAGE and transferred onto nitrocellulose
membrane. Membranes were probed with anti-C terminus calreticulin
antibodies as described under "Experimental Procedures." The
positions of Bio-Rad molecular weight marker proteins are indicated.
CRT, calreticulin.
|
|
Chaperones localized in the lumen of the ER are also known to hydrolyze
ATP (21-25). Therefore, we tested calreticulin's ability to hydrolyze
ATP, in the presence and absence of 100 µM and 1 mM Ca2+, using a coupled enzyme system (38).
Microsomal vesicles isolated from HEK293 cells were used as a control
(Table III) (38). We found that
calreticulin did not hydrolyze ATP under these conditions (Table
III).
View this table:
[in this window]
[in a new window]
|
Table III
ATP hydrolysis by calreticulin
ATPase activity of calreticulin and microsomal vesicles isolated from
HEK293 cells was measured as described under "Experimental
Procedures" (38). Data are means ± S.E. of three independent
experiments. ND, not detectable.
|
|
 |
DISCUSSION |
In this study, we show that environmental conditions in the lumen
of the ER can affect calreticulin's conformation as documented by its
sensitivity to proteolytic with trypsin, elastase, V8 protease, and
cathepsin G. Specifically, the binding of Ca2+,
Zn2+, and Mg2+-ATP to calreticulin appears to
induce conformational changes in the protein, which lead to the
formation of a protease-resistant core structure. The
protease-resistant core always encompasses the P-domain of the protein.
Ca2+ binding protects the N-terminal (N-domain and
P-domain) region of calreticulin, Zn2+ protects its
P-domain, and Mg2+-ATP protects the full-length protein.
These results suggest that the N- and C-domains of calreticulin are
flexible and may undergo frequent, ion-induced changes in conformation.
These conformational changes may explain how Ca2+ and
Zn2+ may alter the function of calreticulin. In this study,
we also show that calreticulin binds ATP. Despite this, the protein
does not hydrolyze Mg2+-ATP, and ATP does not induce
formation of calreticulin oligomers. We conclude that changes in the
concentration of Ca2+, Zn2+, and
Mg2+-ATP in the lumen of the ER significantly affect the
conformation, stability, and function of ER luminal chaperones.
ATP is required to support correct folding and correct disulfide bond
formation in many proteins, and it is an important component of the ER
luminal environment (16-20). For example, ATP is required in the lumen
of the ER for protein phosphorylation (50-57), protein degradation
(58), and protein folding and post-translational modification (16, 17,
22-25). Many chaperones residing in the ER bind and use ATP. For
example, BiP and PDI both bind and hydrolyze ATP (21-25). Grp94 also
binds ATP (19), although neither ATP binding nor hydrolysis is
essential for its peptide binding activity (59). Calreticulin and other
ER chaperones (Grp170, PDI, BiP, ERp72, and Grp94) form
Ca2+-dependent and ATP-sensitive complexes with
misfolded proteins (60, 61). Here we provide the first direct evidence
that calreticulin binds ATP, although we found no evidence that it
hydrolyzes the ATP. We also show that ATP significantly reduces
calreticulin's susceptibility to tryptic digestion, indicating that
ATP stabilizes specific conformation of the protein. Importantly,
calreticulin does not bind GTP, GDP, ADP, and AMP as determined by its
sensitivity to proteolysis.
Fig. 8 shows a proposed model for
conformational changes of calreticulin in the ER lumen. The most
distinctive feature of ATP binding to calreticulin is that it protected
the full-length protein from tryptic digestion (Fig. 8, 1).
This is in contrast to Ca2+ and Zn2+. For
example, Ca2+ binding to the low affinity and high capacity
C-domain results in conformational changes in the C-terminal region of
calreticulin, making it susceptible to proteolysis (Fig. 8,
2 and 3). In the presence of Zn2+,
the N- and C-domain regions of calreticulin also appear to take an
extended conformation that is susceptible to proteolysis (Fig. 8,
2). While there is no obvious nucleotide-binding site in
calreticulin, the protection of the C-domain by ATP is suggestive that
its binding involves the C-domain. This is further supported by the
ATP-dependent protection of the C-domain in the presence of
Zn2+ (Fig. 8, 4). On the other hand, ATP has
less effect on the C-domain of calreticulin in the presence of
Ca2+ (Fig. 8, 5), indicating that
Ca2+ may compete with ATP for binding to the C-domain. ATP
binding could play a role in protection of this region of the protein or in regulation of its activity. Furthermore, ATP causes a slight enhancement in oligosaccharide binding to the P-domain of calreticulin, whereas Ca2+ enhances this binding significantly (14).
Ca2+- and ATP-dependent conformational changes
of calreticulin described here may play an important role in the
regulation of this chaperone function of calreticulin. Recently, Saito
et al. (29) reported that ATP affects interaction between
calreticulin and misfolded proteins. Via these interactions, the
chaperone activity of calreticulin may be modified or controlled by
changes in the concentration of Ca2+ and ATP in the lumen
of the ER. Other recent observations support this suggestion.
Similarly, ATP-induced conformational changes in BiP, another ER
chaperone, are necessary for it to release bound peptide (23, 24). ATP
binding to calreticulin results in dramatic changes in the structure of
the protein (Fig. 8, 1), and it may play a role in the
regulation of calreticulin chaperone activity by increasing its surface
hydrophobicity and enhancing its ability to suppress aggregation of
both glycosylated and nonglycosylated unfolded proteins.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 8.
A hypothetical model of protease sensitivity
of calreticulin. 1, effects of ATP on the proteolysis
of calreticulin. In the presence of ATP, full-length calreticulin is
resistant to digestion with trypsin. Ca2+ binding to the
C-domain of calreticulin in the presence of ATP (5) results
in conformational changes in the protein, leading to unmasking of the
C-domain of the protein. 4 shows that in the presence of ATP
and Zn2+, the N-domain of the protein is an extended
conformation. 2, Zn2+ binding to the N-domain of
calreticulin results in a conformational change, leading to unmasking
of the N- and C-domains of the protein and to the formation of a
protease-resistant core consisting of the P-domain and a part of the
N-domain of the protein. Ca2+ binding to the
C-domain of calreticulin (3) induces conformational change,
resulting in proteolysis of the C-domain and formation of a
protease-resistant core encompassing the N- and P-domains of the
protein.
|
|
Mg2+-ATP binds to calnexin, induces protein
oligomerization, and increases calnexin's sensitivity to proteolysis
(49). In contrast, we found that ATP binding to calreticulin does not
promote its oligomerization; however, it protects calreticulin from
proteolysis. These findings indicate that, while ATP may play an
important role in both proteins, its effects are significantly
different. Importantly, calreticulin and calnexin interact with very
different substrates, and the effects of ATP and Ca2+ may
be responsible for these differences.
Calreticulin binds Zn2+, and Zn2+ is found in
intracellular compartments known to contain calreticulin such as the
ER, sarcoplasmic reticulum, synaptic vesicles, and secretory granules
(62-65). This binding involves highly conserved histidine residues in
the N-domain of the protein (27), and it induces conformational changes
as measured by CD spectroscopy and fluorescence techniques (15, 27,
29). Zn2+ also affects interactions between calreticulin
and other ER chaperones and between calreticulin and misfolded proteins
(15, 27, 29). In this study, we show that
Zn2+-dependent conformational changes in
calreticulin result in the formation of a protease-resistant central
core (Fig. 8, 2). The N-domain and the C-domain of the
protein are unprotected and therefore may be in an extended
conformation (Fig. 8, 2). A recent study reports that
Zn2+ enhances calreticulin's ability to reduce the
aggregation of newly synthesized proteins (29). The N- and C-domains of
calreticulin may be involved in this, via interaction with misfolded
proteins (not glycoproteins) (Fig. 8, 2). Indeed, CD spectra
analysis shows that Zn2+ binding increases the
hydrophobicity of calreticulin, which could enhance its interaction
with hydrophobic regions of misfolded proteins.
The ER is one of the most important sources of intracellular
Ca2+. Although much Ca2+ in the lumen of the ER
is stored by binding to chaperones, a significant portion of the
Ca2+ is free (41). In response to external stimuli, the
concentration of this Ca2+ (free
[Ca2+]ER) fluctuates (41, 42). The free
[Ca2+]ER changes from as high as 500 µM to as low as 1 µM (42). In this study,
we have shown for the first time that Ca2+ binding also
alters calreticulin's conformation as monitored by its susceptibility
to tryptic digestion. At low Ca2+ concentrations (>100
µM, empty Ca2+ stores), Ca2+
binds only to high affinity sites located in the P-domain of calreticulin (28). Under these conditions, calreticulin appears to
exist in a conformation that is "relaxed" (exposed and highly susceptible to proteolysis). When the concentration of Ca2+
is increased to >500 µM (corresponding to full
Ca2+ stores) Ca2+ also binds to the C-domain of
calreticulin. When this happens, the protein appears to undergo a
conformational change, forming a core that is protease-resistant and
that encompasses the highly conserved N-domain and the lectin-like
P-domain of calreticulin, while the C-domain is in an extended
conformation able to bind Ca2+ (Fig. 8, 3). Most
importantly, it is low affinity Ca2+ binding in the
C-domain that is responsible for these changes and not high affinity
binding in the P-domain. It is likely that these
Ca2+-induced conformational changes in calreticulin are
responsible for the Ca2+-dependent interaction
of calreticulin with PDI and ERp57 (Fig. 8, 3) (15, 46).
Furthermore, Ca2+ binding to the ER luminal region of
calnexin induces conformational changes in calnexin as measured by its
resistance to proteinase K digestion (49). Chaperone function of both
calreticulin and the ER luminal region of calnexin may be regulated by
Ca2+-dependent changes in their conformation.
Our results also indicate that the [Ca2+]ER
can significantly affect the conformation and stability of calreticulin. For example, the degradation of both PDI and calreticulin by ERp72 is Ca2+-dependent (66). Specifically,
the degradation of PDI is enhanced at 1 mM
Ca2+, whereas the degradation of calreticulin is inhibited
(66).
The formation of the Ca2+-dependent
protease-resistant 27-kDa fragment of calreticulin may have important
physiological and pathophysiological implications. For example,
autoantibodies against calreticulin are present in the sera of a number
of autoimmune conditions (67). The NH2-terminal region of
calreticulin, corresponding to the Ca2+-resistant 27-kDa
fragment, contains most of the antigenic sites (68). The same
protease-resistant fragment of calreticulin is produced in the VERO76
cells infected with a wild type Rubella virus.3 It is tempting to
speculate that viral infection or other cellular stresses may induce
release of calreticulin and expose the protein to proteolytic enzymes
in the presence of high Ca2+ concentration. This would
result in the production of high levels of protease-resistant
calreticulin fragment with a highly antigenic conformation. A similar
NH2-terminal fragment of calreticulin has been isolated
from an Epstein-Barr virus-immortalized cell line and shown to inhibit
angiogenesis and endothelial cell proliferation (69). In this study,
conformational changes in the ER chaperone calreticulin have been
defined in the presence of Ca2+, Zn2+, and ATP.
It will be important to determine precisely how such conformational
changes regulate the physiological function of the protein
intracellularly. Moreover, proteolytic fragments of calreticulin
released from cells undergoing stress have been observed to interact
with proteins and cells of the immune system. Knowledge of these events
will also help us understand the pathological significance of
calreticulin released into the extracellular environment.
 |
ACKNOWLEDGEMENT |
The superb technical assistance of Monika
Dabrowska is greatly appreciated.
 |
FOOTNOTES |
*
This work was supported by grants from the Canadian
Institutes of Health Research and from the Heart and Stroke Foundations of Alberta (to M. M.), a grant from the Protein Engineering Network of
Centers of Excellence (to C. M. K.), and Arthritis Research Campaign
Grant E0521 (to P. E.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a studentship from the Alberta Heritage Foundation for
Medical Research and from the Heart and Stroke Foundation of Canada.
**
Canadian Institutes of Health Research Senior Scientist and
Medical Scientist of the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: CIHR Group in
Molecular Biology of Membranes, Dept. of Biochemistry, University of
Alberta, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-2256; Fax:
780-492-0886; E-mail: marek.michalak@ualberta.ca.
Published, JBC Papers in Press, June 6, 2000, DOI 10.1074/jbc.M002049200
2
Andrin, C., Corbett, E. F., Johnson, S.,
Dabrowska, M., Campbell, I. D., Eggleton, P., Opas, M., and Michalak,
M. (2000) Protein Purif. Exp., in press.
3
H. Nakhasi, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
[Ca2+]ER, ER lumen
Ca2+ concentration;
PDI, protein-disulfide isomerase;
PAGE, polyacrylamide gel electrophoresis;
Mops, 4-morpholinepropanesulfonic
acid.
 |
REFERENCES |
| 1.
|
Gething, M. J.,
and Sambrook, J.
(1992)
Nature
355,
33-45
|
| 2.
|
Bergeron, J. J. M.,
Brenner, M. B.,
Thomas, D. Y.,
and Williams, D. B.
(1994)
Trends. Biochem. Sci.
19,
124-128
|
| 3.
|
Williams, D. B.
(1995)
Biochem. Cell Biol.
73,
123-132
|
| 4.
|
Trombetta, E. S.,
and Helenius, A.
(1998)
Curr. Opin. Struct. Biol.
8,
587-592
|
| 5.
|
Ferrari, D. M.,
and Söling, H.-D.
(1999)
Biochem. J.
339,
1-10
|
| 6.
|
Ellgaard, L.,
Molinari, M.,
and Helenius, A.
(1999)
Science
286,
1882-1888
|
| 7.
|
Booth, C.,
and Koch, G. E. L.
(1989)
Cell
59,
729-737
|
| 8.
|
Sambrook, J. F.
(1990)
Cell
61,
197-199
|
| 9.
|
Lodish, H. F.,
and Kong, N.
(1990)
J. Biol. Chem.
265,
10893-10899
|
| 10.
|
Lodish, H. F.,
Kong, N.,
and Wikstrom, L.
(1992)
J. Biol. Chem.
267,
12753-12760
|
| 11.
|
Baksh, S.,
Burns, K.,
Andrin, C.,
and Michalak, M.
(1995)
J. Biol. Chem.
270,
31338-31344
|
| 12.
|
Meldolesi, J.,
and Pozzan, T.
(1998)
J. Cell Biol.
142,
1395-1398
|
| 13.
|
Meldolesi, J.
(1998)
Nature
392,
863
|
| 14.
|
Vassilakos, A.,
Michalak, M.,
Lehrman, M. A.,
and Williams, D. B.
(1998)
Biochemistry
37,
3480-3490
|
| 15.
|
Corbett, E. F.,
Oikawa, K.,
Francois, P.,
Tessier, D. C.,
Kay, C.,
Bergeron, J. J. M.,
Thomas, D. Y.,
Krause, K.-H.,
and Michalak, M.
(1999)
J. Biol. Chem.
274,
6203-6211
|
| 16.
|
Dorner, A. J.,
Wasley, L. C.,
and Kaufman, R. J.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
7429-7432
|
| 17.
|
Braakman, I.,
Helenius, J.,
and Helenius, A.
(1992)
Nature
356,
260-262
|
| 18.
|
Dorner, A. J.,
and Kaufman, R. J.
(1994)
Biologicals
22,
103-112
|
| 19.
|
Clairmont, C. A.,
De Maio, A.,
and Hirschberg, C. B.
(1992)
J. Biol. Chem.
267,
3983-3990
|
| 20.
|
Berninsone, P.,
and Hirschberg, C. B.
(1998)
Ann. N. Y. Acad. Sci.
842,
91-99
|
| 21.
|
Munro, S.,
and Pelham, H. R. D.
(1986)
Cell
46,
291-300
|
| 22.
|
Flynn, G. C.,
Chappell, T. G.,
and Rothman, J. E.
(1989)
Science
245,
385-390
|
| 23.
|
Wei, J.,
Gaut, J. R.,
and Hendershot, L. M.
(1995)
J. Biol. Chem.
270,
26677-26682
|
| 24.
|
Wei, J.,
and Hendershot, L. M.
(1995)
J. Biol. Chem.
270,
26670-26676
|
| 25.
|
Guthapfel, R.,
Gueguen, P.,
and Quemeneur, E.
(1996)
J. Biol. Chem.
271,
2663-2666
|
| 26.
|
Michalak, M.,
Corbett, E. F.,
Mesaeli, N.,
Nakamura, K.,
and Opas, M.
(1999)
Biochem. J.
344,
281-292
|
| 27.
|
Baksh, S.,
Spamer, C.,
Heilmann, C.,
and Michalak, M.
(1995)
FEBS Lett.
376,
53-57
|
| 28.
|
Baksh, S.,
and Michalak, M.
(1991)
J. Biol. Chem.
266,
21458-21465
|
| 29.
|
Saito, Y.,
Ihara, Y.,
Leach, M. R.,
Cohen-Doyle, M. F.,
and Williams, D. B.
(1999)
EMBO J.
18,
6718-6729
|
| 30.
|
Ihara, Y.,
Cohen-Doyle, M. F.,
Saito, Y.,
and Williams, D. B.
(1999)
Mol. Cell
4,
331-341
|
| 31.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 32.
|
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
|
| 33.
|
Milner, R. E.,
Baksh, S.,
Shemanko, C.,
Carpenter, M. R.,
Smillie, L.,
Vance, J. E.,
Opas, M.,
and Michalak, M.
(1991)
J. Biol. Chem.
266,
7155-7165
|
| 34.
|
Van Delden, C.,
Favre, C.,
Spat, A.,
Cerny, E.,
Krause, K.-H.,
and Lew, D. P.
(1992)
Biochem. J.
281,
651-656
|
| 35.
|
Stendahl, O.,
Krause, K.-H.,
Krischer, J.,
Jerstrom, P.,
Theler, J. M.,
Clark, R. A.,
and Lew, D. P.
(1994)
Science
265,
1439-1441
|
| 36.
|
Mery, L.,
Mesaeli, N.,
Michalak, M.,
Opas, M.,
Lew, D. P.,
and Krause, K.-H.
(1996)
J. Biol. Chem.
271,
9332-9339
|
| 37.
|
Provencher, S. W.,
and Glöckner, J.
(1981)
Biochemistry
20,
33-37
|
| 38.
|
Poch, E.,
Leach, S.,
Snape, S.,
Cacic, T.,
MacLennan, D. H.,
and Lytton, J.
(1998)
Am. J. Physiol.
275,
C1449-C1458
|
| 39.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 40.
|
Matsudaira, P.
(1987)
J. Biol. Chem.
262,
10035-10038
|
| 41.
|
Meldolesi, J.,
and Pozzan, T.
(1998)
Trends Biochem. Sci.
23,
10-14
|
| 42.
|
Miyawaki, A.,
Llopis, J.,
Heim, R.,
McCaffery, J. M.,
Adams, J. A.,
and Ikura, M.
(1997)
Nature
388,
882-887
|
| 43.
|
Bergmeyer, H.-U.
(1965)
Methods of Enzymatic Analysis
, p. 999, Verlag Chemie, GmbH, New York
|
| 44.
|
Burrell, M. M.
(1993)
Enzymes of Molecular Biology
, Humana Press, Totowa, NJ
|
| 45.
|
Vallee, B. L.,
and Falchuk, K. H.
(1993)
Physiol. Rev.
73,
79-118
|
| 46.
|
Khanna, N. C.,
Tokuda, M.,
and Waisman, D. M.
(1986)
J. Biol. Chem.
261,
8883-8887
|
| 47.
|
Kirchgessner, M.,
Wieninger-Rustemeyer, R.,
and Steinhart, H.
(1980)
Z. Tierphysiol. Tierernahr. Futtermittelkd.
43,
130-137
|
| 48.
|
Furukawa, T.,
Fan, Z.,
Sawanobori, T.,
and Hiraoka, M.
(1993)
J. Physiol. (Lond.)
466,
707-726
|
| 49.
|
Ou, W. J.,
Bergeron, J. J. M.,
Li, Y.,
Kang, C. Y.,
and Thomas, D. Y.
(1995)
J. Biol. Chem.
270,
18051-18059
|
| 50.
|
Hendershot, L. M.,
Ting, J.,
and Lee, A. S.
(1988)
Mol. Cell. Biol.
8,
4250-4256
|
| 51.
|
Leustek, T.,
Toledo, H.,
Brot, N.,
and Weissbach, H.
(1991)
Arch. Biochem. Biophys.
289,
256-261
|
| 52.
|
Rindress, D.,
Lei, X.,
Ahluwalia, J. P.,
Cameron, P. H.,
Fazel, A.,
Posner, B. I.,
and Bergeron, J. J. M.
(1993)
J. Biol. Chem.
268,
5139-5147
|
| 53.
|
Quemeneur, E.,
Guthapfel, R.,
and Gueguen, P.
(1994)
J. Biol. Chem.
269,
5485-5488
|
| 54.
|
Cala, S. E.,
and Jones, L. R.
(1994)
J. Biol. Chem.
269,
5926-5931
|
| 55.
|
Csermely, P.,
Miyata, Y.,
Schnaider, T.,
and Yahara, I.
(1995)
J. Biol. Chem.
270,
6381-6388
|
| 56.
|
Chen, N. Q.,
Davis, A. T.,
Canbulat, E. C.,
Liu, Y. X.,
Goueli, S.,
McKenzie, B. A.,
Eccleston, E. D., Jr.,
Ahmed, K.,
and Holtzman, J. L.
(1996)
Biochemistry
35,
8299-8306
|
| 57.
|
Cala, S. E.
(1999)
Biochem. Biophys. Res. Commun.
259,
233-238
|
| 58.
|
Hirschberg, C. B.,
Robbins, P. W.,
and Abeijon, C.
(1998)
Annu. Rev. Biochem.
67,
49-69
|
| 59.
|
Wearsch, P. A.,
and Nicchitta, C. V.
(1997)
J. Biol. Chem.
272,
5152-5156
|
| 60.
|
Nigam, S. K.,
Goldberg, A. L.,
Ho, S.,
Rohde, M. F.,
Bush, K. T.,
and Sherman, M.
(1994)
J. Biol. Chem.
269,
1744-1749
|
| 61.
|
Dierks, T.,
Volkmer, J.,
Schlenstedt, G.,
Jung, C.,
Sandholzer, U.,
Zachmann, K.,
Schlotterhose, P.,
Neifer, K.,
Schmidt, B.,
and Zimmermann, R.
(1996)
EMBO J.
15,
6931-6942
|
| 62.
|
Frederickson, C. J.,
Perez-Clausell, J.,
and Danscher, G.
(1987)
J. Histochem. Cytochem.
35,
579-583
|
| 63.
|
Holm, I. E.,
Andreasen, A.,
Danscher, G.,
Perez-Clausell, J.,
and Nielsen, H.
(1988)
Histochemistry
89,
289-293
|
| 64.
|
Reddy, A. G.,
Devi, B. G.,
Rao, S. B.,
and Gupta, P. D.
(1989)
Cytobios
60,
21-26
|
| 65.
|
Picello, E.,
Damiani, E.,
and Margreth, A.
(1992)
Biochem. Biophys. Res. Commun.
186,
659-667
|
| 66.
|
Urade, R.,
Takenaka, Y.,
and Kito, M.
(1993)
J. Biol. Chem.
268,
22004-22009
|
| 67.
|
Eggleton, P.,
Reid, K. B.,
Kishore, U.,
and Sontheimer, R. D.
(1997)
Lupus
6,
564-571
|
| 68.
|
Eggleton, P.,
Ward, F. J.,
Johnson, S.,
Khamashta, M. A.,
Hughes, G. R. V.,
Hajela, V.,
Michalak, M.,
Corbett, E. F.,
Staines, N. A.,
and Reid, K. B. M.
(2000)
Clin. Exp. Immunol.
120,
384-391
|
| 69.
|
Pike, S. E.,
Yao, L.,
Jones, K. D.,
Cherney, B.,
Appella, E.,
Sakaguchi, K.,
Nakhasi, H.,
Teruya-Feldstein, J.,
Wirth, P.,
Gupta, G.,
and Tosato, G.
(1998)
J. Exp. Med.
188,
2349-2356
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. E. Grespin, G. M. C. Bonamy, V. R. Roggero, N. G. Cameron, L. E. Adam, A. P. Atchison, V. M. Fratto, and L. A. Allison
Thyroid Hormone Receptor {alpha}1 Follows a Cooperative CRM1/Calreticulin-mediated Nuclear Export Pathway
J. Biol. Chem.,
September 12, 2008;
283(37):
25576 - 25588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Nanney, C. D. Woodrell, M. R. Greives, N. L. Cardwell, A. C. Pollins, T. A. Bancroft, A. Chesser, M. Michalak, M. Rahman, J. W. Siebert, et al.
Calreticulin Enhances Porcine Wound Repair by Diverse Biological Effects
Am. J. Pathol.,
September 1, 2008;
173(3):
610 - 630.
[Abstract]
[Full Text]
|